These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9101012)

  • 1. Compatibility of nebulizer solution admixtures.
    Joseph JC
    Ann Pharmacother; 1997 Apr; 31(4):487-9. PubMed ID: 9101012
    [No Abstract]   [Full Text] [Related]  

  • 2. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
    Kamin W; Schwabe A; Krämer I
    J Cyst Fibros; 2006 Dec; 5(4):205-13. PubMed ID: 16678502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the physical-chemical compatibility of cromolyn sodium nebulizer solution: bronchodilator inhalant solution admixtures.
    Emm T; Metcalf JE; Lesko LJ; Chai MF
    Ann Allergy; 1991 Feb; 66(2):185-9. PubMed ID: 1899784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of budesonide inhalation suspension with four nebulizing solutions.
    McKenzie JE; Cruz-Rivera M
    Ann Pharmacother; 2004 Jun; 38(6):967-72. PubMed ID: 15084687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium, or acetylcysteine sodium.
    Bonasia PJ; McVicar WK; Bill W; Ong S
    Respir Care; 2008 Dec; 53(12):1716-22. PubMed ID: 19025708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osmolality and pH of anti-asthmatic drug solutions.
    Desager KN; Van Bever HP; Stevens WJ
    Agents Actions; 1990 Nov; 31(3-4):225-8. PubMed ID: 2150739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
    Kamin W; Schwabe A; Krämer I
    Int J Chron Obstruct Pulmon Dis; 2007; 2(4):599-607. PubMed ID: 18268934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osmolarity of solutions used in nebulization].
    Portel L; Tunon de Lara JM; Vernejoux JM; Weiss I; Taytard A
    Rev Mal Respir; 1998 Apr; 15(2):191-5. PubMed ID: 9608990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma and other wheezing disorders of childhood.
    Keeley D; McKean M
    Clin Evid; 2003 Jun; (9):287-317. PubMed ID: 15366138
    [No Abstract]   [Full Text] [Related]  

  • 11. Asthma and other wheezing disorders in infants and children.
    Keeley D; McKean M
    Clin Evid; 2004 Jun; (11):328-59. PubMed ID: 15652008
    [No Abstract]   [Full Text] [Related]  

  • 12. Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.
    Krämer I; Schwabe A; Lichtinghagen R; Kamin W
    Pharmazie; 2007 Oct; 62(10):760-6. PubMed ID: 18236781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma and other wheezing disorders in children.
    Keeley D; McKean M
    Clin Evid; 2005 Dec; (14):238-62. PubMed ID: 16620406
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
    Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
    Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium.
    Lee TY; Chen CM; Lee CN; Chiang YC; Chen HY
    Am J Health Syst Pharm; 2005 Apr; 62(8):828-33. PubMed ID: 15821276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual compatibility of common nebulizer medications with 7% sodium chloride solution.
    Fox LM; Foushee JA; Jackson DJ; Watson H
    Am J Health Syst Pharm; 2011 Jun; 68(11):1032-5. PubMed ID: 21593232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthma.
    Cates C; FitzGerald JM
    Clin Evid; 2002 Jun; (7):1325-43. PubMed ID: 12230750
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modifications in asthma patients' knowledge of the use of inhalers].
    Labori Ruiz JR; Araujo Heredia T
    Aten Primaria; 2007 Jun; 39(6):325-6. PubMed ID: 17555666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse nebulization in pneumatic devices.
    Gradoń L; Sosnowski TR; Podolec Z
    Int J Occup Saf Ergon; 1999; 5(1):31-42. PubMed ID: 10602637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metered dose inhaler aerosol deposition in a model of the human respiratory system and a comparison with clinical deposition studies.
    Velasquez DJ; Gabrio B
    J Aerosol Med; 1998; 11 Suppl 1():S23-8. PubMed ID: 10180729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.